This inventor holds 1 USPTO granted patent. Top assignee: Sarepta Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Uditha Dealwis: Innovator in AAV Capsid Protein Analysis
Introduction
Uditha Dealwis is a notable inventor based in Cambridge, MA, specializing in the analysis of adeno-associated virus (AAV) capsid proteins. His innovative work contributes significantly to the field of gene therapy and biotechnology.
Latest Patents
Uditha holds a patent titled "Methods for Analyzing AAV Capsid Proteins." This patent reflects his expertise and dedication to advancing the understanding of viral vectors used in therapeutic applications. He has 1 patent to his name, showcasing his contributions to scientific research.
Career Highlights
Currently, Uditha is employed at Sarepta Therapeutics, Inc., a company known for its focus on genetic medicine. His role at Sarepta allows him to apply his innovative ideas in a practical setting, contributing to the development of groundbreaking therapies.
Collaborations
Throughout his career, Uditha has collaborated with esteemed colleagues, including Kunal Daud and Ju Li. These partnerships enhance the research environment and foster innovation in their respective fields.
Conclusion
Uditha Dealwis exemplifies the spirit of innovation in biotechnology through his work on AAV capsid proteins. His contributions are paving the way for advancements in gene therapy, making a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile